ArticlebioRxiv : the preprint server for biology2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer.
Xin Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.